The pregnant women living with hiv antiretroviral therapy coverage for pmtct in Kyrgyzstan currently stands at 100%, which is 8% (8.7%) higher than 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Kyrgyzstan
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Kyrgyzstan
PMTCT antiretroviral therapy coverage
More indicators for Kyrgyzstan
Male unintentional poisoning
1.3
-0.1
(2019)
Female wasting in children
2.1%
-0.8%
(2018)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar123
intl dollar0
(2021)
Birth registration
98.9%
+0.9%
(2018)
Contraceptive modern method prevalence
37.8%
-2.1%
(2018)
Kyrgyzstan PMTCT antiretroviral therapy coverage between 2001 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 100% | +8% |
| 2021 | 92% | -2% |
| 2020 | 94% | +23% |
| 2019 | 71% | -2% |
| 2018 | 73% | +3% |
| 2017 | 70% | +3% |
| 2016 | 67% | +14% |
| 2015 | 53% | -21% |
| 2014 | 74% | +6% |
| 2013 | 68% | +5% |
| 2012 | 63% | +28% |
| 2011 | 35% | -13% |
| 2010 | 48% | -16% |
| 2009 | 64% | +34% |
| 2008 | 30% | +21% |
| 2007 | 9% | -12% |
| 2006 | 21% | -7% |
| 2005 | 28% | -17% |
| 2004 | 45% | +45% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% |